Results 171 to 180 of about 10,389 (214)

Glucocerebrosidase mutations in subjects with parkinsonism [PDF]

open access: yesMolecular Genetics and Metabolism, 2004
Recent studies showing an association between glucocerebrosidase deficiency and parkinsonism in Gaucher disease prompted an examination of the glucocerebrosidase gene sequence (GBA) and enzyme activity in brain samples from 57 subjects carrying the diagnosis of Parkinson disease.
Ellen Sidransky, Özlem Göker-Alpan
exaly   +3 more sources

Glucocerebrosidase mutations in a Serbian Parkinson's disease population

open access: yesEuropean Journal of Neurology, 2013
peer reviewedBACKGROUND AND PURPOSE: To screen for glucocerebrosidase (GBA) mutations in a Serbian Parkinson's disease (PD) population. METHODS: Glucocerebrosidase exons 8-11 harbouring the most common mutations were sequenced in 360 patients with PD and
Nikola Kresojevic   +2 more
exaly   +2 more sources

Glucocerebrosidase dysfunction in neurodegenerative disease

Essays in Biochemistry, 2021
Abstract Parkinson's disease (PD) and related neurodegenerative disorders, termed the synucleinopathies, are characterized pathologically by the accumulation of protein aggregates containing α-synuclein (aSyn), resulting in progressive neuronal loss.
Sarah M. Brooker, Dimitri Krainc
openaire   +2 more sources

Glucocerebrosidase (Gaucher disease)

Human Mutation, 1996
Gaucher disease is the most common glycolipid storage disorder, characterized by storage of the glycolipid, glucocerebroside in the liver, spleen, and marrow. The most prevalent form of Gaucher disease is designated type I (MIM 230800). Patients with type I disease may have hepatomegaly, splenomegaly, bone lesions, and less commonly, lung disease, but ...
E, Beutler, T, Gelbart
openaire   +2 more sources

Glucocerebrosidase recombinant allele: Molecular evolution of the glucocerebrosidase gene and pseudogene in primates

Blood Cells, Molecules, and Diseases, 2005
Glucocerebrosidase is a lysosomal enzyme that hydrolyses the beta-glycosidic linkage of glucocerebroside, a ubiquitous sphingolipid present in the plasma membrane of mammalian cells. Deleterious mutations in the glucocerebrosidase gene result in Gaucher disease, the most prevalent lysosomal storage disease. Humans have one glucocerebrosidase functional
Julie R, Wafaei, Francis Y M, Choy
openaire   +2 more sources

Brain Glucocerebrosidase in Gaucher's Disease

Archives of Neurology, 1982
Using glucocerebroside labeled with carbon 14 as the substrate, we determined that homogenates of brain tissue from both neuropathic and nonneuropathic cases of Gaucher's disease were profoundly deficient (more than 85%) in glucocerebrosidase activity.
L B, Daniels   +4 more
openaire   +2 more sources

Parkinsonism, dementia and glucocerebrosidase mutations

Journal of Neurology, 2013
Objectives: Previous associations between mitochondrial DNA (mtDNA) and idiopathic Parkinson disease (PD) have been inconsistent and contradictory. Our aim was to resolve these inconsistencies and determine whether mtDNA has a significant role in the risk of developing PD.
Kathryn, Peall, Neil P, Robertson
openaire   +2 more sources

Molecular Properties of Lysosomal Glucocerebrosidase

1988
In Gaucher disease the membrane-associated lysosomal enzyme glucocerebrosidase is deficient (1). Three clinical phenotypes of Gaucher disease are discriminated: type 1, the adult non-neuronopathic form, type 2, the infantile neuronopathic form and type 3, the juvenile neuronopathic form (1).
van Weely, S.   +7 more
openaire   +2 more sources

Glucocerebrosidase mutations and the pathogenesis of Parkinson disease [PDF]

open access: yesAnnals of Medicine, 2013
Parkinson disease (PD) is the second most common neurodegenerative disease after Alzheimer disease with a lifetime risk in the UK population of almost 5%. An association between PD and Gaucher disease (GD) derived from the observation that GD patients and their heterozygous carrier relatives were at increased risk of PD.

exaly   +3 more sources

The neuroinflammatory role of glucocerebrosidase in Parkinson's disease

Neuropharmacology, 2022
The lysosomal enzyme glucocerebrosidase (GCase), encoded by the GBA1 gene, is a membrane-associated protein catalyzing the cleavage of glucosylceramide (GlcCer) and glucosylsphingosine (GlcSph). Homologous GBA1 mutations cause Gaucher disease (GD) and heterologous mutations cause Parkinson's disease (PD).
Ru-Xue Bo   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy